Clinical Trial Update: European Study of Dronedarone in Atrial Fibrillation [Phase 3]

View source ↗

Summary

A Phase 3 European study evaluating dronedarone for atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Dronedarone (dronedarone)
• Multaq (dronedarone)

Snippet

Sponsor: Sanofi | Conditions: Atrial Fibrillation | Phase 3 | Status: COMPLETED